Mitcham, Australia

Marcin Jakub Kowalczyk

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nacuity Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marcin Jakub Kowalczyk. Retrieved from https://idiyas.com/inventor/marcin-jakub-kowalczyk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marcin Jakub Kowalczyk: Innovator in Pharmaceutical Chemistry

Introduction

Marcin Jakub Kowalczyk is a notable inventor based in Mitcham, Australia. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative methods for preparing important compounds.

Latest Patents

Kowalczyk holds a patent for a "Method for preparation of N-acetyl cysteine amide and derivatives thereof." This patent outlines methods for making, isolating, and purifying N-acetylcysteine amide and its derivatives. The process involves several steps, including the reaction of cystine with methanol and a chlorinating reagent, followed by the formation of various intermediates and the final product, N-acetylcysteine amide.

Career Highlights

Kowalczyk is currently associated with Nacuity Pharmaceuticals, Inc., where he applies his expertise in pharmaceutical development. His work focuses on creating innovative solutions that can enhance therapeutic options in medicine.

Collaborations

One of his notable collaborators is G Michael Wall, with whom he has worked on various projects within the pharmaceutical sector.

Conclusion

Marcin Jakub Kowalczyk's contributions to pharmaceutical chemistry through his patent and work at Nacuity Pharmaceuticals, Inc. highlight his role as an innovator in the field. His methods for preparing N-acetyl cysteine amide represent a significant advancement in pharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…